Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 40761 - 40780 out of 498428 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Belgium | (L01BC07) azacitidine | AZACITIDINE KABI 25 mg/mL | 1 injectieflacon 100 mg poeder voor suspensie voor injectie, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | FRESENIUSKABI |
| Belgium | (L01CC) colchicine derivatives | COLCHICINE OPOCALCIUM 1 mg | 20 tabletten, 1 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MAYOLYBENELUX |
| Belgium | (L01EB04) osimertinib (adm: O) | TAGRISSO 40 mg | 30 filmomhulde tabletten, 40 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA |
| Belgium | (L01EB04) osimertinib (adm: O) | TAGRISSO 80 mg | 30 filmomhulde tabletten, 80 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECA |
| Belgium | (L01FX27) epcoritamab | TEPKINLY 4 mg | 1 injectieflacon 0,8 mL concentraat voor oplossing voor injectie, 5 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIE |
| Belgium | (L01FX27) epcoritamab | TEPKINLY 48 mg | 1 injectieflacon 0,8 mL oplossing voor injectie, 60 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | ABBVIE |
| Belgium | (L01XL) antineoplastic cell and gene therapy | EBVALLO | 6 injectieflacons 1 mL dispersie voor injectie, 1 mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoproliferative Disorders | PIERREFABRESANTEBENELUX |
| Belgium | (L01XX52) venetoclax | VENCLYXTO 10 mg | 14 filmomhulde tabletten, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | ABBVIE |
| Belgium | (L01XX52) venetoclax | VENCLYXTO 100 mg | 7 filmomhulde tabletten, 100 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | ABBVIE |
| Belgium | (L01XX52) venetoclax | VENCLYXTO 50 mg | 7 filmomhulde tabletten, 50 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | ABBVIE |
| Belgium | (L03AX16) plerixafor (adm: P) | MOZOBIL 20 mg/ml | 1 injectieflacon 1,2 mL oplossing voor injectie, 20 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma; Hematopoietic Stem Cell Transplantation; Lymphoma | SANOFIBELGIUM |
| Belgium | (L04AA40) cladribine (adm: O) | MAVENCLAD 10 mg | 1 tablet, 10 mg | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | MERCK |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 20 mg/mL | 1 injectieflacon 10 mL concentraat voor oplossing voor infusie, 20 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 20 mg/mL | 1 injectieflacon 20 mL concentraat voor oplossing voor infusie, 20 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 20 mg/mL | 1 injectieflacon 4 mL concentraat voor oplossing voor infusie, 20 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 162 mg | 12 voorgevulde pennen 0,9 mL oplossing voor injectie, 180 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 162 mg | 4 voorgevulde pennen 0,9 mL oplossing voor injectie, 180 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 162 mg | 4 voorgevulde spuiten 0,9 mL oplossing voor injectie, 180 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC07) tocilizumab (adm: P) | TYENNE 162 mg | 12 voorgevulde spuiten 0,9 mL oplossing voor injectie, 180 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FRESENIUSKABI |
| Belgium | (L04AC17) tildrakizumab (adm: P) | ILUMETRI 100 mg | 1 voorgevulde pen 1 mL oplossing voor injectie, 100 mg/mL | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | ALMIRALL |
Pages
